Fecal Microbiota Transplantation and Hydrocortisone Ameliorate Intestinal Barrier Dysfunction and Improve Survival in a Rat Model of Cecal Ligation and Puncture-Induced Sepsis

被引:34
作者
Assimakopoulos, Stelios F. [1 ]
Papadopoulou, Iliana [2 ]
Bantouna, Dimitra [3 ]
De Lastic, Anne-Lise [4 ]
Rodi, Maria [4 ]
Mouzaki, Athanasia [4 ]
Gogos, Charalambos A. [1 ]
Zolota, Vasiliki [3 ]
Maroulis, Ioannis [2 ]
机构
[1] Univ Patras, Dept Internal Med, Med Sch, Patras 26504, Greece
[2] Univ Patras, Dept Surg, Med Sch, Patras, Greece
[3] Univ Patras, Dept Pathol, Med Sch, Patras, Greece
[4] Univ Patras, Dept Internal Med, Div Hematol, Med Sch, Patras, Greece
来源
SHOCK | 2021年 / 55卷 / 05期
关键词
Apoptosis; cytokines; endotoxin; gut barrier; microbiota; occludin; sepsis; GUT MICROBIOTA; SHOCK; THERAPY;
D O I
10.1097/SHK.0000000000001566
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction: Sepsis is a life-threatening syndrome which can progress to multiple organ dysfunction with high mortality. Intestinal barrier failure exerts a central role in the pathophysiological sequence of events that lead from sepsis to multiple organ dysfunction. The present study investigated the role of hydrocortisone (HC) administration and fecal microbiota transplantation (FMT) in several parameters of the gut barrier integrity, immune activation, and survival, in a model of polymicrobial sepsis in rats. Methods: Forty adults male Wistar rats were randomly divided into four groups: sham (group I), cecal ligation and puncture (CLP) (group II), CLP + HC (2.8 mg/kg, intraperitoneally single dose at 6 h) (group III), and CLP + FMT at 6 h (group IV). At 24 h post-CLP, ileal tissues were harvested for histological and immunohistochemical analyses while endotoxin, IL-6, and IL-10 levels in systemic circulation were determined. In a second experiment the same groups were observed for 7 days for mortality, with daily administration of hydrocortisone (group III) and FMT (group IV) in surviving rats. Results: HC administration and FMT significantly reduced mortality of septic rats by 50%. These interventions totally reversed intestinal mucosal atrophy by increasing villous density and mucosal thickness (mu m, mean +/- SD: Group I: 620 +/- 35, Group II: 411 +/- 52, Group III: 622 +/- 19, Group IV: 617 +/- 44). HC and FMT reduced the apoptotic body count in intestinal crypts whereas these increased the mitotic/apoptotic index. Activated caspase-3 expression in intestinal crypts was significantly reduced by HC or FMT (activated caspase-3 (+) enterocytes/10 crypts, mean +/- SD: Group I: 1.6 +/- 0.5, Group II: 5.8 +/- 2.4, Group III: 3.6 +/- 0.9, Group IV: 2.3 +/- 0.6). Both treatments increased Paneth cell count and decreased intraepithelial CD3(+) T lymphocytes and inflammatory infiltration of lamina propria to control levels. In the sham group almost the total of intestinal epithelial cells expressed occludin (92 +/- 8%) and claudin-1 (98 +/- 4%) and CLP reduced this expression to 34 +/- 12% for occludin and 35 +/- 7% for claudin-1. Administration of HC significantly increased occludin (51 +/- 17%) and claudin-1 (77 +/- 9%) expression. FMT exerted also a significant restoring effect in tight junction by increasing occludin (56 +/- 15%) and claudin-1 (84 +/- 7%) expression. The beneficial effects of these treatments on gut barrier function led to significant reduction of systemic endotoxemia (EU/mL, mean +/- SD: Group I: 0.93 +/- 0.36, Group II: 2.14 +/- 1.74, Group III: 1.48 +/- 0.53, Group IV: 1.61 +/- 0.58), while FMT additionally decreased IL-6 and IL-10 levels. Conclusion: Fecal microbiota transplantation and stress dose hydrocortisone administration in septic rats induce a multifactorial improvement of the gut mechanical and immunological barriers, preventing endotoxemia and leading to improved survival.
引用
收藏
页码:666 / 675
页数:10
相关论文
共 29 条
[1]   The role of the gut microbiota in the treatment of inflammatory bowel diseases [J].
Aggeletopoulou, Ioanna ;
Konstantakis, Christos ;
Assimakopoulos, Stelios F. ;
Triantos, Christos .
MICROBIAL PATHOGENESIS, 2019, 137
[2]   Hydrocortisone plus Fludrocortisone for Adults with Septic Shock [J].
Annane, D. ;
Renault, A. ;
Brun-Buisson, C. ;
Megarbane, B. ;
Quenot, J. -P. ;
Siami, S. ;
Cariou, A. ;
Forceville, X. ;
Schwebel, C. ;
Martin, C. ;
Timsit, J. -F. ;
Misset, B. ;
Benali, M. Ali ;
Colin, G. ;
Souweine, B. ;
Asehnoune, K. ;
Mercier, E. ;
Chimot, L. ;
Charpentier, C. ;
Francois, B. ;
Boulain, T. ;
Petitpas, F. ;
Constantin, J. -M. ;
Dhonneur, G. ;
Baudin, F. ;
Combes, A. ;
Bohe, J. ;
Loriferne, J. -F. ;
Amathieu, R. ;
Cook, F. ;
Slama, M. ;
Leroy, O. ;
Capellier, G. ;
Dargent, A. ;
Hissem, T. ;
Maxime, V. ;
Bellissant, E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (09) :809-818
[3]   The Role of the Gut Barrier Function in Health and Disease [J].
Assimakopoulos, Stelios F. ;
Triantos, Christos ;
Maroulis, Ioannis ;
Gogos, Charalambos .
GASTROENTEROLOGY RESEARCH, 2018, 11 (04) :261-263
[4]   Gut-origin sepsis in the critically ill patient: pathophysiology and treatment [J].
Assimakopoulos, Stelios F. ;
Triantos, Christos ;
Thomopoulos, Konstantinos ;
Fligou, Fotini ;
Maroulis, Ioannis ;
Marangos, Markos ;
Gogos, Charalambos A. .
INFECTION, 2018, 46 (06) :751-760
[5]  
Assimakopoulos Stelios F, 2011, World J Gastrointest Pathophysiol, V2, P123, DOI 10.4291/wjgp.v2.i6.123
[6]   Glucocorticoid receptor dimers control intestinal STAT1 and TNF-induced inflammation in mice [J].
Ballegeer, Marlies ;
Van Looveren, Kelly ;
Timmermans, Steven ;
Eggermont, Melanie ;
Vandevyver, Sofie ;
Thery, Fabien ;
Dendoncker, Karen ;
Souffriau, Jolien ;
Vandewalle, Jolien ;
Van Wyngene, Lise ;
De Rycke, Riet ;
Takahashi, Nozomi ;
Vandenabeele, Peter ;
Tuckermann, Jan ;
Reichardt, Holger M. ;
Impens, Francis ;
Beyaert, Rudi ;
De Bosscher, Karolien ;
Vandenbroucke, Roosmarijn E. ;
Libert, Claude .
JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (08) :3265-3279
[7]   Antibiotic-Induced Changes in the Intestinal Microbiota and Disease [J].
Becattini, Simone ;
Taur, Ying ;
Pamer, Eric G. .
TRENDS IN MOLECULAR MEDICINE, 2016, 22 (06) :458-478
[8]   An overview of fecal microbiota transplantation: techniques, indications, and outcomes [J].
Brandt, Lawrence J. ;
Aroniadis, Olga C. .
GASTROINTESTINAL ENDOSCOPY, 2013, 78 (02) :240-249
[9]   European consensus conference on faecal microbiota transplantation in clinical practice [J].
Cammarota, Giovanni ;
Ianiro, Gianluca ;
Tilg, Herbert ;
Rajilic-Stojanovic, Mirjana ;
Kump, Patrizia ;
Satokari, Reetta ;
Sokol, Harry ;
Arkkila, Perttu ;
Pintus, Cristina ;
Hart, Ailsa ;
Segal, Jonathan ;
Aloi, Marina ;
Masucci, Luca ;
Molinaro, Antonio ;
Scaldaferri, Franco ;
Gasbarrini, Giovanni ;
Lopez-Sanroman, Antonio ;
Link, Alexander ;
De Groot, Pieter ;
de Vos, Willem M. ;
Hoegenauer, Christoph ;
Malfertheiner, Peter ;
Mattila, Eero ;
Milosavljevic, Tomica ;
Nieuwdorp, Max ;
Sanguinetti, Maurizio ;
Simren, Magnus ;
Gasbarrini, Antonio .
GUT, 2017, 66 (04) :569-580
[10]   Fecal Microbiota Transplantation Prevents Intestinal Injury, Upregulation of Toll-Like Receptors, and 5-Fluorouracil/Oxaliplatin-Induced Toxicity in Colorectal Cancer [J].
Chang, Ching-Wei ;
Lee, Hung-Chang ;
Li, Li-Hui ;
Chiau, Jen-Shiu Chiang ;
Wang, Tsang-En ;
Chuang, Wei-Hung ;
Chen, Ming-Jen ;
Wang, Horng-Yuan ;
Shih, Shou-Chuan ;
Liu, Chia-Yuan ;
Tsai, Tung-Hu ;
Chen, Yu-Jen .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (02)